NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-272-2003-0-PCT-02 Analogs of Thalidomide as Potential Angiogenesis Inhibitors PCT PCT PCT/US2004/22242 Expired
NHLBI E-254-2003-2-PCT-01 Use of Nitrite Salts for the Treatment of Cardiovascular Conditions PCT PCT COMB PCT/US2004/021985 Expired
NHLBI E-254-2003-3-PCT-01 USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS PCT PCT COMB PCT/US2004/022232 Expired
NINDS E-132-1996-0-US-05 IMMUNOTOXIN (MAB-RICIN) FOR THE TREATMENT OF FOCAL MOVEMENT DISORDERS US DIV 10/886,557 Abandoned
NHLBI E-254-2003-3-JP-18 Use of Nitrite Salts for the Treatment of Cardiovascular Conditions JP DIV 2011-280763 Abandoned
NHLBI E-254-2003-2-CA-06 USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS CA National Stage 2537222 Abandoned
NCI E-249-2004-0-US-01 DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment US 60/586,539 Abandoned
NICHD E-079-2003-0-US-02 DIFFUSION TENSOR AND Q-SPACE MRI SPECIMEN CHARACTERIZATION US ORD 10/888,917 7643863 Abandoned PDF
NICHD E-079-2003-0-PCT-03 DT and q-Space MRI Specimen Characterization PCT PCT PCT/US2004/22027 Expired
NIAID E-272-2004-0-US-01 Protozoan Derived Antagonist of CCR5 US 60/586,884 Abandoned
NCI E-287-2003-3-EP-06 SYNTHETIC ANTIPROLIFERATIVE FACTOR GLYCOPEPTIDES AND METHODS OF USE EP National Stage 04777402.1 Expired
NCI E-287-2003-3-FR-10 SYNTHETIC ANTIPROLIFERATIVE FACTOR GLYCOPEPTIDES AND METHODS OF USE FR EP 04777402.1 Expired
NCI E-287-2003-3-DE-09 SYNTHETIC ANTIPROLIFERATIVE FACTOR GLYCOPEPTIDES AND METHODS OF USE DE EP 04777402.1 Expired
NCI E-287-2003-3-GB-11 SYNTHETIC ANTIPROLIFERATIVE FACTOR GLYCOPEPTIDES AND METHODS OF USE GB EP 04777402.1 Expired
NCI E-287-2003-3-AU-04 A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE AU National Stage 2004264853 Abandoned
NCI E-287-2003-3-PCT-01 A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE PCT PCT COMB PCT/US2004/021239 Expired
NIDDK E-226-2003-0-PCT-02 New Potent Monoamine Oxidase Inhibitors PCT PCT PCT/US2004/21505 Expired
NCI E-287-2003-3-US-02 A Novel Antiproliferative Factor and Methods of Use In Bladder Cancer US ORD 10/882,586 Abandoned
NIDDK E-141-2003-0-US-01 Monoclonal Antibodies to HIV-1 VPR and Methods of Using Same US 60/585,282 Abandoned
NCI E-287-2003-3-CA-08 A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE CA National Stage 2530803 Abandoned
NIAID E-245-2001-0-US-04 Targeting Gene Transfers To Certain Cell Types By Pseudotyping With Viral Glycoprotein US CON 10/860,878 Abandoned
NIAID E-217-2004-0-US-01 Safer Attenuated Virus Vaccines With Missing or Diminished Latency of Infection US 60/583,399 Abandoned
NIDDK E-264-2003-0-CA-04 Pyridinium Compounds To Treat Cystic Fibrosis And Other IL-8 Dependent Disorders CA National Stage 2530075 Expired
NIDDK E-264-2003-0-EP-05 AMPHIPHILIC PYRIDINIUM COMPOUNDS, METHOD OF MAKING AND USE THEREOF EP National Stage 04756271.5 Expired
NIDDK E-264-2003-0-US-06 Pyridinium Compounds To Treat Cystic Fibrosis And Other IL-8 Dependent Disorders US National Stage 10/560,590 7893094 Issued PDF
NIDDK E-264-2003-0-AU-03 Pyridinium Compounds To Treat Cystic Fibrosis And Other IL-8 Dependent Disorders AU National Stage 2004253541 Abandoned
NCI E-124-2001-1-BE-08 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor BE EP 02789873.3 Expired
NCI E-124-2001-1-AT-07 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor AT EP 02789873.3 Expired
NCI E-124-2001-1-DK-11 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor DK EP 02789873.3 Expired
NCI E-124-2001-1-NL-16 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor NL EP 02789873.3 Expired
NCI E-124-2001-1-ES-12 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor ES EP 02789873.3 Expired
NCI E-124-2001-1-CH-09 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor CH EP 02789873.3 Expired
NCI E-124-2001-1-GB-14 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor GB EP 02789873.3 Expired
NCI E-124-2001-1-SE-17 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor SE EP 02789873.3 Expired
NCI E-124-2001-1-FR-13 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor FR EP 02789873.3 Expired
NCI E-124-2001-1-DE-10 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor DE EP 02789873.3 Expired
NCI E-124-2001-1-IT-15 Peptide Agonists of Prostate-Specific Antigen, and Uses Therefor IT EP 02789873.3 Expired
NIDDK E-264-2003-0-PCT-02 Pyridinium Compounds To Treat Cystic Fibrosis And Other IL-8 Dependent Disorders PCT PCT PCT/US2004/020718 Expired
NCI E-244-2004-0-US-01 The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof US 60/583,263 Abandoned
NCI E-281-2003-0-US-01 Identification Of Neutrophil Granule Protein Cathepsin G as a Novel Chemotactic Agonist for the G Protein Formyl Peptide Receptor FPR US 60/581,765 Abandoned
NCI E-238-2001-0-US-03 Novel Metastasis Suppressor Gene on Human Chromosome 8 US National Stage 10/499,515 Abandoned
NCI E-170-1997-1-US-02 Molecular Computing Elements: Gates and Flip-Flops US CON 10/873,774 Abandoned
NCI E-288-2000-0-US-03 DNA Array Sequence Selection (The Immunochip) US National Stage 10/451,189 Abandoned
NIAID E-357-2001-1-US-02 Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine to Prevent Disease Caused by West Nile Virus US National Stage 10/871,775 8778671 Expired PDF
NIDCD E-222-2003-1-PCT-01 Human Bitter Taste Receptor Variants PCT PCT COMB PCT/US2004/019489 Expired
NIDDK E-102-2004-0-US-01 An Improved Method For The Generation Of Polycolonal Antibodies To Treat Leukocyte Mediated Counter-adapted Immunity US 60/581,201 Abandoned
NCI E-075-2004-0-US-01 METHODS FOR THE IDENTIFICATION AND USE OF COMPOUNDS SUITABLE FOR THE TREATMENT OF DRUG RESISTANCE US 60/580,397 Abandoned
NIAAA E-230-2005-0-US-01 Neurotrophic Factors For The Treatment Of Stroke And Neurological Disorders US 60/580,376 Abandoned
NCI E-105-2004-1-US-01 Minimally Immunogenic Germline Sequence Variants Of Humanized COL-1 Antibody And Their Use US 60/580,839 Abandoned
NIDCD E-222-2003-1-AU-04 Variants of Human Taste Receptor Genes AU National Stage 2004258071 Abandoned